
HeartFlow Inc (HTFL) Stock Forecast & Price Target
HeartFlow Inc (HTFL) Analyst Ratings
Bulls say
HeartFlow is a leader in non-invasive CAD diagnosis with strong revenue growth potential, high gross margins, and potential to expand their TAM with AI-powered software capabilities. However, competition and risks such as the ongoing DOJ investigation could impact the company's financials and target price, which currently applies a 15.0x multiple to a projected 2026 revenue of $210.5 million. Further information is needed to fully assess the potential impact of the DOJ investigation on HeartFlow's financials and determine the likelihood of a settlement.
Bears say
HeartFlow is a medical technology company that offers innovative software and artificial intelligence solutions for the diagnosis and management of coronary artery disease. While the company has shown promising growth and technological advancements, its high debt and one-time non-cash charge associated with its IPO are concerning factors. Additionally, the market for CAD solutions is highly competitive, and it remains to be seen how well HeartFlow's technology will hold up against its rivals.
This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.
HeartFlow Inc (HTFL) Analyst Forecast & Price Prediction
Start investing in HeartFlow Inc (HTFL)
Order type
Buy in
Order amount
Est. shares
0 shares